Companies: 10,795·Total market cap: $144.5T

Menicon Co Ltd

Menicon Co Ltd

MECNYOTCHealthcare

$88.63

+$0.00(+0.00%)

Market Cap$26.9B

P/E Ratio—

52W High$88.63

52W Low$88.63

Avg Volume36.14458

Open$88.63

Beta0.15

股票排行：Medical - Instruments & Supplies·Healthcare·查看全部市值排行 →

Menicon Co Ltd（MECNY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MECNY · 截至 Jun 8, 2026

关键指标

EPS (TTM)$6.89Earnings history

PE Ratio (TTM)12.9×PE Ratio deep dive

Revenue (TTM)$120.0BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding1.21BShares outstanding history

Next EarningsTBAEarnings history

探索 Menicon Co Ltd 数据

分析师预测—

股息不分红

营收$121.5B+4.56%

盈利EPS $4.63+24.13%

市盈率12.9×

财务快照

FY 2025Revenue$121.49B▲ +4.56% YoY

202320242025

FY 2025Net Income$5.62B▲ +23.87% YoY

202320242025

FY 2025EPS$4.63▲ +24.13% YoY

202320242025

TTM:Revenue: $119.97BNet Income: $4.81BEPS: $6.89View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$88.63+0.00%$26.9B #2

EssilorLuxottica S.A.

$199.02-1.41%$92.4B #3

EssilorLuxottica S.A.

$99.69+0.67%$91.8B #4

Fresenius SE & Co. KGaA

$10.65-1.39%$96.0B #5

$23.54-1.67%$94.4B #6

HOYA Corporation

$177.20+3.67%$59.3B

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y+0.00%

关于 Menicon Co Ltd

CEOKoji Kawaura

IPO DateOct 1, 2021

Employees4,325

CountryUS

Websitemenicon.co.jp

Menicon Co Ltd operates as a specialized manufacturer within the contact lens industry. Its operations involve the worldwide manufacturing, distribution, and trade (both export and import) of contact …

Medical - Instruments & Supplies HealthcareOTCADRUS

关于股票概览与关键数据

Menicon Co Ltd（MECNY）是 Medical - Instruments & Supplies 行业的 Healthcare 类公司，于 Oct 1, 2021 在 OTC 上市。截至最近交易日，MECNY 股价为 $88.63，市值约为 $26.9B。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2025 财年 Menicon Co Ltd 营收 $121.5B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Menicon Co Ltd（MECNY）股价为 $88.63，在 OTC 上市，52周区间为 $88.63 – $88.63。

MECNY 最新股价MECNY quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议